Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
RESMED INC
Report date November 16, 2017 · Filed November 17, 2017
Section 16 reporting ended · disclosed 2017-11-17. Current position is not established by this disclosure.
No balance rows disclosed in this filing.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 29, 2017 Filed Oct 3, 2017 16:42 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 25,934 | $0.00 Strike: $38.98 | $0.00 |
DisclosureSEC source: 0001140361-17-037277 · doc1.xml · derivative · entry 5 ROBERTS CHRISTOPHER G · CIK 0001186112 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: ResMed Common Stock · 25,934 shares Expires 2019-11-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction to exercise options and hold shares acquired through purchase. F2 · derivative.exercise_date: Options vest in full on (i) the first November 11 following the grant date, or (ii) the first annual shareholder's meeting following grant date. Read SEC document |
| September 29, 2017 Filed Oct 3, 2017 16:42 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 25,934 | $38.98 | $1,010,907.32 |
DisclosureSEC source: 0001140361-17-037277 · doc1.xml · nonDerivative · entry 1 ROBERTS CHRISTOPHER G · CIK 0001186112 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 224,337 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction to exercise options and hold shares acquired through purchase. Read SEC document |
| April 24, 2017 Filed Apr 25, 2017 23:16 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 28,403 | $0.00 Strike: $27.58 | $0.00 |
DisclosureSEC source: 0001140361-17-016775 · doc1.xml · derivative · entry 7 ROBERTS CHRISTOPHER G · CIK 0001186112 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: ResMed Common Stock · 28,403 shares Expires 2018-11-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction approved to exercise options and hold shares acquired through purchase. F2 · derivative.exercise_date: Options vest in full on (i) the first November 11 following the grant date, or (ii) the first annual shareholder's meeting following grant date. Read SEC document |
| April 24, 2017 Filed Apr 25, 2017 23:16 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 24,390 | $0.00 Strike: $33.70 | $0.00 |
DisclosureSEC source: 0001140361-17-016775 · doc1.xml · derivative · entry 6 ROBERTS CHRISTOPHER G · CIK 0001186112 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: ResMed Common Stock · 24,390 shares Expires 2017-11-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction approved to exercise options and hold shares acquired through purchase. F2 · derivative.exercise_date: Options vest in full on (i) the first November 11 following the grant date, or (ii) the first annual shareholder's meeting following grant date. Read SEC document |
| April 24, 2017 Filed Apr 25, 2017 23:16 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 28,403 | $27.58 | $783,354.74 |
DisclosureSEC source: 0001140361-17-016775 · doc1.xml · nonDerivative · entry 2 ROBERTS CHRISTOPHER G · CIK 0001186112 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 198,403 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction approved to exercise options and hold shares acquired through purchase. Read SEC document |
| April 24, 2017 Filed Apr 25, 2017 23:16 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 24,390 | $33.70 | $821,943.00 |
DisclosureSEC source: 0001140361-17-016775 · doc1.xml · nonDerivative · entry 1 ROBERTS CHRISTOPHER G · CIK 0001186112 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction approved to exercise options and hold shares acquired through purchase. Read SEC document |
| February 22, 2017 Filed Feb 24, 2017 20:22 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 15,000 | $72.10 | $1,081,500.00 |
DisclosureSEC source: 0001140361-17-009111 · doc1.xml · nonDerivative · entry 2 ROBERTS CHRISTOPHER G · CIK 0001186112 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Cabbit Pty Ltd Disclosed balance after: 298,900 F1 · shares: Trade executed as CDI on Australian Securities Exchange converted at 10:1. F2 · price: ASX sale price average of A$ 9.38 was converted using the foreign exchange rate on the transaction date of 1 AUD to .76862 USD. Trade was executed in multiple trades ranging in from A$ 9.38 to A$ 9.385 or USD 72.09 to 72.14. Read SEC document |
| February 20, 2017 Filed Feb 21, 2017 19:11 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 10,000 | $71.91 | $719,100.00 |
DisclosureSEC source: 0001140361-17-008291 · doc1.xml · nonDerivative · entry 2 ROBERTS CHRISTOPHER G · CIK 0001186112 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Cabbit Pty Ltd Disclosed balance after: 313,900 F1 · shares: Trade executed as CDI on Australian Securities Exchange converted at 10:1. F2 · price: ASX sale price average of A$ 9.3715 was converted using the foreign exchange rate on the transaction date of 1 AUD to .76743 USD. Trade was executed in multiple trades ranging in from A$ 9.37 to A$ 9.40 or USD 71.90 to 72.13. Read SEC document |
| November 16, 2016 Filed Nov 18, 2016 16:13 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock Options · Derivative | 23,277 | $0.00 Strike: $57.76 | $0.00 |
DisclosureSEC source: 0001140361-16-087166 · doc1.xml · derivative · entry 5 ROBERTS CHRISTOPHER G · CIK 0001186112 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,277 Underlying: ResMed Common Stock · 23,277 shares Expires 2023-11-16 F1 · derivative.exercise_date: Options vest in full on the first November 11 following the grant date, or the first annual shareholders meeting following grant date. Read SEC document |
| October 19, 2016 Filed Oct 24, 2016 16:27 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock Options · Derivative | 36,000 | $0.00 Strike: $25.54 | $0.00 |
DisclosureSEC source: 0001140361-16-083348 · doc1.xml · derivative · entry 5 ROBERTS CHRISTOPHER G · CIK 0001186112 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: ResMed Common Stock · 36,000 shares Expires 2016-12-17 F2 · derivative.exercise_date: Options vest in full (a) on the first Nov. 11 following the grant date or (b) the first annual shareholder's meeting following grant date. Read SEC document |
| October 19, 2016 Filed Oct 24, 2016 16:27 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 36,000 | $25.54 | $919,440.00 |
DisclosureSEC source: 0001140361-16-083348 · doc1.xml · nonDerivative · entry 1 ROBERTS CHRISTOPHER G · CIK 0001186112 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,610 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise options and hold shares acquired through purchase. F1 · shares: Exercise options and hold shares acquired through purchase. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.